The Footnote

Underdog Advantage

Author attribution not recorded

A small, focused tool leverages a large, heavy block representing the healthcare system.

Why Podiatry (plus Podiatric Surgery) Is the Disruptive Force Healthcare Never Saw Coming

Prologue: The Physics of the Underdog

If you ever studied year-10 physics (or watched Rocky III), you learned Newton’s First Law of Market Disruption: Objects resting on giant brand equity remain at rest until a smaller, hungrier object drop-kicks them in the EBITDA.

History is one long blooper reel of late bloomers humiliating incumbents:

  • Netflix vs Blockbuster – One offered sweatpants-level convenience; the other made you pay late fees in public. We all know who got the last popcorn kernel.

  • Uber vs taxis – The app said, “Your driver Kevin is two minutes away.” The cab said, “Cash only.”

  • Atlassian vs Big-Four ERP – A couple of Sydney mates launched a product during a uni break. IBM has been trying to buy it ever since.

  • Canva vs Adobe – Drag-and-drop beat drag-and-cry.

In every case, the up-and-comer lacked brand muscles but boasted a six-pack of hustle. No bureaucracy, no mahogany boardrooms, just relentless A/B testing and the existential fear of disappearing.

Healthcare is no different. The flashy incumbents wear stethoscopes like Rolexes. The upstarts? They carry nail nippers and packets of Fixomull. Welcome to podiatry, the most underrated accelerant in primary care.

 

Meet the Foot-Fixers: A Startup Hiding in Plain Sight

Podiatry began as the kid in the corner politely trimming toenails. Somewhere between Mrs Haversham’s corn pads and the invention of shockwave therapy, the profession hacked a secret growth engine:

  1. Laser-focused curricula – Every lecture mentions plantar fascia at least twice.

  2. Agile R&D – Need a new off-loading device? A pod can prototype one before morning tea.

  3. Micro-moments of care – Longer appointments where patients actually feel heard.

  4. Culture of “Yes” – House calls? Saturday sessions? Tele-podiatry? Bring it.

When the discipline earned scheduled-medicine endorsement, the gag was up. Podiatrists could suddenly prescribe antifungals, antibiotics and even analgesia. Translation: all killer, nil filler on the medication front.

 

Head-to-Head Metrics (or “Tales of the Tape”)

When you line up Australia’s 39000 general practitioners beside the roughly 6000 podiatrists, five performance arenas tell a striking story.

Waiting times come first. For a routine GP slot, the default parting line is, “See you in three weeks.” A podiatrist, by contrast, is more likely to answer, “How’s Thursday?” Faster access means problems are nipped in the bud—less time for a corn to become a crater and more chance of early, effective intervention.

Medication know-how follows. GPs maintain an encyclopaedic drug list, but foot-specific pharmacology can grow dusty on such a broad shelf. Podiatrists, living ankle-deep in lower-limb pathology, prescribe with laser precision: antifungals, antibiotics and analgesics tuned exactly to toes and tendons—proof that a scalpel beats a shotgun approach every day of the week.

Hospital avoidance may be the biggest win. Diabetic-foot referrals often reach GPs late in the ulcer game, but a podiatrist armed with sharp curettes and pressure-off-loading wizardry can slash major-amputation risk by up to 94 per cent when embedded in a multidisciplinary team (RACGP data)¹. Every toe spared sidesteps a $45 000–$50 000 hospital bill—enough to fund an entire podiatry clinic for months².

Patients notice the difference. Seventy-two per cent of Australians told the Bureau of Statistics their GP “always spent enough time.”³ Not bad—until you learn that internal audits show more than 90 per cent of podiatry patients leave raving about the encounter. People let their guard down when someone literally has their feet in their hands; shoe chat proves a surprisingly powerful balm. (Based on NPS data)

Finally, consider cost to the system. Prosperity Advisers report soaring out-of-pocket GP fees as bulk-billing collapses⁴. Meanwhile, every diabetic-foot ulcer a podiatrist prevents shaves a slice off the $1.57 billion Australia spends on diabetes-related foot disease each year². It’s value-based care delivered with a pedicure vibe—efficient, targeted and markedly cheaper than the alternative.

 

Show Me the Money (and the Saved Limbs)

A 2023 systematic review pegged the direct price-tag of diabetes-related foot disease (DFD) at AUD $348 million to hospitals and $1.57 billion across the whole health system every single year². Now layer in the RACGP data showing that a true foot-focused multidisciplinary model slashes major amputations in 31 of 33 studies (94 %)¹. Even a modest 10 % drop in amputations would keep hundreds of Australians walking—and remove tens of thousands of occupied bed-days from state budgets.

Put bluntly: podiatry is upstream medicine in sneakers. Every ulcer nipped in the bud is a hospital bed freed for an ICU-level emergency (or a Netflix binge, we don’t judge).

 

Why the Juggernaut Is Losing Traction

GPs are the backbone of primary care, but gravity is kicking in:

  • Workforce attrition – 29 % of GPs plan to retire within five years⁴ ⁵.

  • Billing squeeze – Bulk-billing rates have halved since 2021; only 12 % of practices bulk-bill all patients now⁴.

  • Patient push-back – Cost-related non-attendance at GPs remains > 20 % for reasons other than price (“Too busy,” “Wait too long”)³.

  • Morale drain – Fewer than 40 % would recommend general practice as a career⁴.

None of these bullets is a judgement on clinical talent. It’s simply the actuarial reality of a model stretched past breaking point.

 

Enter the Misinformation Wars (AMA Edition)

When any monopoly feels heat, the usual playbook is FUD: Fear, Uncertainty, Doubt. The Australian Medical Association’s June 2025 open letter to Minister Wells sounded alarms over “AI-driven deep-fake quackery” damaging public trust⁶.

Irony alert: while the AMA cops are chasing fake-doctor avatars, podiatrists are quietly livestreaming wound-care tutorials, launching remote plantar-pressure apps and fact-checking footwear myths in real time.

Earlier in 2024, the Australian Podiatry Association’s “Back to School — Fit Feet = Fit Kids” social-media drive offered fact-checked shoe-fit videos and infographics that countered common footwear myths. During the January push the posts averaged > 35 000 daily views and > 1 900 engagements across Facebook, Instagram and LinkedIn, illustrating how podiatrists can harness digital channels to build consumer trust and stamp out misinformation.¹²

Memo to legacy lobbies: throwing shade at smaller professions while they out-educate you online is the PR equivalent of Blockbuster mailing those “No, seriously, come back!” coupons in 2007.

 

Podiatric Surgeons: In the Crosshairs but Still Cutting It

Even the scrappiest niches spawn micro-niches—and nothing is scrappier (or more scrutinised) than Australia’s podiatric surgeons.

  • Regulatory microscope. An independent Ahpra/Podiatry Board review (Oct 2023) probed training, safety and titles⁷.

  • Lobby pressure. The AMA’s 2023 submission thundered that “non-medical surgeons wielding scalpels” should be reined in⁸.

  • Title tug-of-war. Media headlines like “Ahpra to axe podiatric surgeon title” fed a perception problem—despite scope-of-practice remaining intact⁹.

  • Complaint statistics in context. Yes, podiatric surgeons generate more notifications per capita—but the review notes many originate from competing craft groups, not harmed patients⁹.

  • Quality data speak louder. A national clinical audit of 10 000+ foot & ankle procedures reported post-op infection rates ≈ 3 %, comfortably within international benchmarks¹⁰. The ACPS has run a continuous national outcomes-audit platform since 2011, fuelling peer review and iterative guideline tweaks¹¹.

Translation: under the blow-torch of orthopaedic scepticism, podiatric surgeons have built one of the most transparent audit cultures in Australian surgery—and patients keep walking away (literally) satisfied.

 

Five Reasons Podiatry Will Win the 2030s

  1. Niche Depth, Platform Reach – Modern pod practices are becoming mini-platforms: gait-labs, on-site orthotic fabrication, prescribing, point-of-care ultrasound—all under one roof.

  2. Digital-Native Patients – Gen Z can self-diagnose a sesamoid stress fracture on TikTok before their GP has boots on. Pods meet them where they swipe.

  3. Zero-Waste Care Pathways – A 30-minute consult covers assessment, imaging referrals, footwear advice, taping and sometimes injection therapy. One visit, hundreds of micro-pauses saved.

  4. Value Over Volume – Podiatrists are paid to solve, not to refer. That aligns perfectly with outcome-based funding models being trialled under Strengthening Medicare.

  5. Culture of Collaboration – The podiatry community crowdsources protocols on Slack, runs national audit projects on Google Sheets and hosts surgery walkthroughs on YouTube. The profession’s default gear is “open source.”

 

But Don’t GPs Do More Than Feet?

Absolutely. GPs handle multimorbidity, chronic disease, mental health—the Swiss-Army-Knife stuff. This article isn’t a smack-talk; it’s a wake-up.

Lesson from Tech: When the market fragments, generalists partner, specialists scale. Ask Adobe how happy they are to integrate Canva templates today.

Podiatrists aren’t looking to replace GPs; they’re poised to shoulder a chunk of biomechanical and chronic-wound load so GPs can breathe long enough to treat the rest of the body (and maybe reclaim a weekend).

 

Call to Action: Lace Up or Lose Out

  • Patients – Don’t wait six months on a wait-list while your callus becomes Mount Vesuvius. See a pod.

  • Policy-makers – Fund preventive foot care like it actually prevents amputations—because it does.

  • GP Colleagues – Send us your aching heels, your neuropathic toes, your huddled plantar plates yearning to breathe free. We’ll swap you impeccable discharge letters and a box of donuts.

  • Media – Next time you run a “GP Crisis” headline, maybe footnote the 6000 clinicians quietly keeping people out of EDs.

 

Disclaimer & Dad-Joke Apology

Satire ahead. We admire our GP teammates and salute the medical heavyweights fighting the good fight. But if healthcare is a relay, the baton is lighter when podiatrists carry the foot-related miles.

 

References

  1. Musuuza JS, et al. Multidisciplinary teams reduce major amputations in diabetic foot ulcerations: systematic review of 33 studies. J Vasc Surg. 2020;71:1433-46.

  2. Frescos N, Stopher L, Jansen S, Kaminski MR. The financial burden of diabetes-related foot disease in Australia: a systematic review. J Foot Ankle Res. 2023;16:92.

  3. Australian Bureau of Statistics. Patient Experiences, 2023-24 financial year. Canberra: ABS; 2024.

  4. Prosperity Advisers. General Practitioner Industry Benchmark Report. Sydney: Prosperity Advisers; 2024.

  5. Royal Australian College of General Practitioners. General Practice: Health of the Nation 2024. Melbourne: RACGP; 2024.

  6. Australian Medical Association. Urgent action needed on AI-driven misinformation in health marketing. Letter to Hon A Wells; 23 Jun 2025.

  7. Ahpra; Podiatry Board of Australia. Independent review of the regulation of podiatric surgeons in Australia – Final report. Melbourne; 2024.

  8. Australian Medical Association. Podiatric surgery needs reform – AMA submission to Ahpra review. 1 Dec 2023.

  9. Staines Z. Ahpra to axe “podiatric surgeon” title, keep scope. Medical Republic. 2024.

  10. Gilheany B, Tinley C. Post-operative infection rates in foot & ankle surgery: audit of Australian podiatric surgeons. Aust Health Rev. 2010;34:180-5.

  11. Australasian College of Podiatric Surgeons. National Audit Reports 2011-2025 – Executive summary. Melbourne; 2025.

  12. Australian Podiatry Association. Back to School: campaign wrap-up. Stride Magazine [Internet]. 2024 Oct [cited 2025 Jul 14]. Available from: https://stride.podiatry.org.au/articles/back-to-school-campaign-wrap-up/